Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 183
2
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

Understanding immune system paralysis in times of bacterial stress

Sepsis is a life-threatening condition in which the body's immune response to infection injures its own tissues...

The Dogs of Chernobyl Research Initiative

The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from the...

Backer Badge Funded